New state-of-the-art robotics lab to be created at Maynooth University

Intel and Maynooth University continue to partner through education and research with co-funding for new robotics lab

2023-06-14

(Press-News.org) The Maynooth University Foundation is delighted to announce a significant donation from Intel Ireland to support the creation of a state-of-the-art robotics lab. The lab will provide MU students with invaluable hands-on learning experiences using cutting-edge robotic technologies.

The establishment of the robotics lab at a total cost of €150,000 will equip Maynooth University students with access to innovative robotic technologies and equipment used by engineers from Intel and other companies. This hands-on experience will enable them to bridge the gap between classroom learning and real-world application, empowering them to develop and refine their skills in robotics.

The new robotics lab is set to become a hub of innovation, where students can explore and experiment with robotics, pushing the boundaries of technology and unlocking new possibilities. This new lab will support students in MU’s current degree programmes in Robotics and Intelligent Devices, Electronic Engineering and Computer Science.

The gift from Intel is coupled with an investment from the University, demonstrating the power of public-private partnerships to fuel innovation and improve student learning experiences.

The establishment of the robotics lab further strengthens the ties between Intel and Maynooth University.

Dave Selkirk, the Director of Advanced Analytics MSO Automation at Intel Ireland, said: “We are very proud of our close partnership with Maynooth University, a close neighbour of ours here in North Kildare. The development of key infrastructure in the area of robotics will provide an important opportunity for students to gain practical experience in an evolving technology field that has massive potential in Advanced High-Volume Manufacturing.”

Vice-President External Affairs at Maynooth University Rebecca Doolin said: "We are tremendously grateful to our neighbour and partner Intel for supporting the development of a new robotics lab, which will give Maynooth students hands-on learning opportunities to work with the same robots Intel engineers down the road are using, bringing their classroom learning to life."

Doolin noted a Memorandum of Understanding (MOU) signed by Maynooth University and Intel in 2019, and its significance in creating a strategic research and innovation partnership.

“Over the years, Maynooth University has developed a strong partnership with Intel that has fostered collaboration in various areas, including student skills and experiences, research, innovation, and community engagement. As neighbours in a vibrant and fast-growing region of Ireland, today's announcement not only deepens the ties between Intel and MU, but also demonstrates the positive impacts on student learning and innovation that such partnerships can yield.”

Prof Gerry Lacey, Head of Engineering at Maynooth University, said: “Robotics and AI are creating new industries, making agriculture more sustainable and revolutionising transportation. We are excited that Intel’s support will help our students to become leaders in creating this new future.”

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Inhaled beta-2 agonists are not associated with a lower risk of Parkinson’s disease

2023-06-14

Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been associated with a reduced risk of Parkinson’s disease in some previous epidemiological studies, this association was not found in a recent register-based study from the University of Eastern Finland. The findings were published in Clinical Epidemiology. Accumulation of the alpha-synuclein protein in the brain plays a central role in Parkinson’s ...

Slightly lost bumblebees use scent to find their way home

2023-06-14

Put yourself in the exoskeleton of a bumblebee for a moment: your world would be a riot of colors and scents, both essential to guide your search for pollen and nectar. Bumblebees have excellent vision: they have a pair of compound eyes that can distinguish UV and most colors except red, plus three additional simple eyes specialized in detecting polarized light. Their sense of smell dwarfs ours: approximately 100 times more sensitive, and capable of sniffing out illegal drugs or explosives at airports, confirming pregnancy in women, or detecting cancers and diabetes in early-stage patients. Now, ...

New way of identifying proteins supports drug development

2023-06-14

All living cells contains proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg have discovered a way to identify proteins even without looking at their structure. Their method is faster, easier and more reliable than previous methods. Currently, the general view is that each protein’s structure is what controls its function in cells. The atomic sequences, meaning how the atoms are arranged in the proteins, create the protein’s structure and shape. But there are many proteins that lack a well-defined structure. Researcher Gergely Katona ...

Researchers succeed in arranging nanoscale quantum sensors on desired targets

2023-06-14

Summary: The University of Tokyo scientists achieve the delicate task of arranging quantum sensors at a nanoscale, allowing them to detect extremely small variations in magnetic fields. The high-resolution quantum sensors will have potential uses in quantum materials and electronic device research. For example, the sensors can help develop hard disks that use nano-magnetic materials as storage elements. This is the world’s first successful high-resolution magnetic field imaging using a nanoscale arrangement of quantum sensors. Sensors surround us in our daily life, from garage lights ...

Community-wide program to support teen parents serves as a model for engagement

2023-06-14

WASHINGTON (June 14, 2023) – More than 500 adolescent mothers, caregivers and community members benefitted from a coordinated “collective impact” model to provide support aimed at addressing the litany of strains faced by teen parents, according to a case study published Wednesday in the journal Pediatrics. Known as the District of Columbia Network for Parenting and Expectant Teens (DC NEXT), the model used well-tested pillars of community organization to provide services and care that bolstered the well-being of pregnant ...

New imaging technique captures COVID-19’s impact on the brain

2023-06-14

A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain. The new imaging technique known as correlated diffusion imaging (CDI) was developed by systems design engineering professor Alexander Wong and recently used in a groundbreaking study by scientists at Baycrest’s Rotman Research Institute and Sunnybrook Hospital in Toronto. “Some may think COVID-19 affects just the lungs,” Dr. Wong said. “What was found is that this new MRI technique that we created ...

Prediction of age of onset of SCA3 and DRPLA by survival analysis using machine learning

2023-06-14

Niigata, Japan – Using machine learning, the Department of Neurology at Niigata University has developed a model to predict the asymptomatic probability at each age from the current age and number of CAG repeats in carriers of spinocerebellar degeneration. Polyglutamine diseases such as DRPLA and SCA3 are caused by an expansion of CAG repeats in the causative gene. In polyglutamine diseases, the number of CAG repeats is known to be inversely related to age of onset. Parametric survival analysis has traditionally been used to predict age of onset, but a more accurate prediction method has been desired. We ...

Remission rates of 1 in 100 people with type 2 diabetes in real world data

2023-06-14

Niigata, Japan - The phenomenon of improvement of glucose to levels in a normal range and cessation of the need for medication can occur in some patients diagnosed with type 2 diabetes who are provided with lifestyle therapy, temporary pharmacotherapy, bariatric surgery, or combinations of these treatments. However, this phenomenon is not yet fully understood in routine care settings, and many factors remain to be clarified. Moreover, since there are differences in insulin secretion and resistance between East Asian and Western populations, the natural history of diabetes seems to differ widely between Western populations and East Asians. Therefore, ...

Sharpening Occam’s Razor

2023-06-14

In science, the explanation with the fewest assumptions is most likely to be true. Called “Occam’s Razor,” this principle has guided theory and experiment for centuries. But how do you compare between abstract concepts? In a new paper, philosophers from UC Santa Barbara and UC Irvine discuss how to weigh the complexity of scientific theories by comparing their underlying mathematics. They aim to characterize the amount of structure a theory has using symmetry — or the aspects of an object that remain the same when other changes are made. After much ...

C-Path’s PSTC receives positive FDA response for drug-induced pancreatic injury biomarkers

2023-06-14

Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical trials TUCSON, Ariz., June 13, 2023 — Critical Path Institute (C-Path) today announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) in the U.S. Food and Drug Administration (FDA) issued a Biomarker Letter of Support (LOS) for four pancreatic injury safety biomarkers identified and evaluated by C-Path’s Predictive Safety Testing Consortium's (PSTC) Pancreatic Injury Working Group (PIWG). This set of biomarkers will help increase the ability ...

LAST 30 PRESS RELEASES:

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC